Advanced Search

Avian myeloblastosis (ATCC® VR-1542AS-Gt™)

Classification: Retrovirus, Avian Type C Retrovirus Group  /  Product Format: frozen

Permits and Restrictions

View Permits

Classification Retrovirus, Avian Type C Retrovirus Group
Agent Avian myeloblastosis
Strain antiserum against AMV RT [NCI HE 599]
Applications
goat antiserum against the Avian Myeloblastosis Virus (AMV) Reverse Transcriptase (RT)
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Isolation
The antiserum was prepared by immunizing female goat 75F000682 with disrupted purified AMV RT.
Product Format frozen
Storage Conditions -70C
Comments
Titer: unknown
The whole serum 76S000168 was harvested 4/1/76.
The protein concentration of the final preparation is 67 mg/ml.
Date of preparation: 10/21/75
The original preparation was contributed by the National Cancer Institute.
goat antiserum against the Avian Myeloblastosis Virus (AMV) Reverse Transcriptase (RT)
The antiserum was prepared by immunizing female goat 75F000682 with disrupted purified AMV RT.
-70C
Effect on Host
goat antiserum against the Avian Myeloblastosis Virus (AMV) Reverse Transcriptase (RT)
Cryopreservation
Storage temperature: -70C
Effect on Host
goat antiserum against the Avian Myeloblastosis Virus (AMV) Reverse Transcriptase (RT)
Name of Depositor National Cancer Institute
Special Collection NCRR Contract
Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation
Product Sheet
Product Sheet
Certificate of Analysis
Certificate of Analysis
SDS
SDS